Registry for Analysis of Quality of Life, Normal Organ Toxicity and Survival of Pediatric Patients Treated With Proton Therapy

Pediatric Cancer Patients Clinical Trial

Status Recruiting

Clinical Trial Summary

The study aim of this study is to evaluate the effect of proton therapy on quality of life and long-term normal tissue toxicities of the pediatric cancer patients. Based on these results, the predictive model of long-term normal tissue toxicities, survival, and quality of life could be recognized. Risk-adapted treatment strategy based on the predictive model in pediatric cancer patients could be established.

Clinical Trial Description

n/a

Study Design

Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Pediatric Cancer Patients

Clinical Trial Details

NCT number	NCT02644993
Study type	Interventional
Source	Samsung Medical Center
Contact	Do Hoon Lim, MD, PhD
Phone	82-2-3410-2612
Email	dh8.lim@samsung.net
Status	Recruiting
Phase	N/A
Start date	November 2015

View Details

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT04873284` - Comparative Study of Fosaprepitant and Aprepitant for the Prevention of Chemotherapy-induced Nausea and Vomiting in Pediatric Caner Patients	N/A
Completed	`NCT02836041` - Sleep in Hospitalized Children at MSKCC
Recruiting	`NCT04831359` - Tissue Doppler Assessment of Right Ventricle Function in Pediatrics Underwent Chemotherapy